REDWOOD CITY, Calif., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (Nasdaq:AVGR) a manufacturer of image-guided, catheter-based systems used by physicians to treat peripheral arterial disease and pioneer of the lumivascular approach to treating vascular disease, today announced that it will release its financial results for the fourth quarter and full year of 2014 after the close of trading on Thursday, March 12, 2015. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
Individuals interested in listening to the conference call may do so by dialing (855) 638-4817 for domestic callers or (262) 912-6051 for international callers. To listen to a live webcast, please visit the investor relations section of Avinger's website at: www.avinger.com.
A replay of the call will be available beginning March 12, 2015 at 4:30pm PT/7:30pm ET through midnight on March 13, 2015. To access the replay, dial (855) 859-2056 or (404) 537-3406 and reference Conference ID: 90291483. The webcast will also be available on Avinger's website for one year following the completion of the call.
About Avinger, Inc. - Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease, or PAD. The company manufactures and sells a suite of products including the Lightbox imaging console, as well as the Wildcat, Kittycat, and the Ocelot family of catheters. Avinger is based in Redwood City, California.
CONTACT: INVESTOR CONTACT Leigh Salvo (415) 513-1281 Email: firstname.lastname@example.orgSource:Avinger Inc.